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Nuclear receptors are transcription factors that regu-
late diverse cellular processes. In canonical acti-
vation, ligand availability is sufficient to produce
receptor binding, entraining downstream signaling.
The mineralocorticoid receptor (MR) is normally acti-
vated by aldosterone, which is produced in both vol-
ume depletion and hyperkalemia, states that require
different homeostatic responses. We report phos-
phorylation at S843 in the MR ligand-binding domain
that prevents ligandbinding and activation. In kidney,
MRS843-P is found exclusively in intercalated cells of
the distal nephron. In volume depletion, angiotensin
II and WNK4 signaling decrease MRS843-P levels,
whereas hyperkalemia increases MRS843-P. Dephos-
phorylation of MRS843-P results in aldosterone-
dependent increases of the intercalated cell apical
proton pump and Cl/HCO3
 exchangers, increasing
Cl reabsorption and promoting increased plasma
volume while inhibiting K+ secretion. These findings
reveal a mechanism regulating nuclear hormone re-
ceptor activity and implicate selective MR activation
in intercalated cells in thedistinct adaptive responses
to volume depletion and hyperkalemia.
INTRODUCTION
Nuclear receptors play key roles in signaling throughout the
body, modifying transcription of target genes in response to
ligand binding (Mangelsdorf et al., 1995). Steroid hormone re-
ceptors reside in the cytoplasm in the apo (unliganded) state,
bound to proteins such as heat shock protein 90. Ligand bind-
ing induces release from these proteins, translocation to the
nucleus, binding to specific DNA sequences, and recruitment
of coactivators or corepressors, resulting in altered transcription660 Cell Metabolism 18, 660–671, November 5, 2013 ª2013 Elsevierof targets (McKenna and O’Malley, 2002; Pratt, 1997). Other
members, such as the retinoic acid, thyroid hormone, and perox-
isome proliferator-activated receptors, are bound to DNA with
corepressors in the apo state and activated by ligand binding
(Glass and Rosenfeld, 2000; McKenna and O’Malley, 2002). In
these classical models of receptor activation, binding and acti-
vation are constitutive in the presence of ligand.
Posttranslational modifications of nuclear receptors can
modify receptor activity. Phosphorylation can modulate interac-
tion with coactivators (Rochette-Egly et al., 1997; Choi et al.,
2010), prevent receptor dimerization and DNA binding (Chen
et al., 1999), and promote ubiquitination, leading to either degra-
dation (Lin et al., 2002) or stabilization (Yin et al., 2006). Phos-
phorylation of the amino terminus of PPARg is suggested to
reduce ligand binding (Shao et al., 1998); the mechanism of
this effect is unknown. There have been no reports of posttrans-
lational modification of the ligand binding domain (LBD) altering
ligand binding.
The mineralocorticoid receptor (MR, encoded by NR3C2) is
expressed in renal epithelia, smoothmuscle, endothelium, cardi-
omyocytes, and hippocampal neurons (Gomez-Sanchez et al.,
2006; Nguyen Dinh Cat et al., 2010). MR is activated by the
steroid aldosterone and also by cortisol in cells that do not
express the enzyme 11b-hydroxysteroid dehydrogenase type 2
(11bHSD2) (Arriza et al., 1987; Funder et al., 1988).
Aldosterone is produced by adrenal glomerulosa in two phys-
iologic states. Intravascular volume depletion leads to activation
of the renin-angiotensin system (RAS), increasing levels of angio-
tensin II (AII). AII signaling via the type 1 AII receptor (AGTR1), a G
protein-coupled receptor, increases aldosterone production.
Hyperkalemia (increased plasma K+ levels) also increases
aldosterone production by directly depolarizing glomerulosa
cells (Spa¨t and Hunyady, 2004).
MR is in epithelia of the distal nephron, comprising the distal
convoluted tubule (DCT) and both principal cells and intercalated
cells of the connecting tubule (CNT) and collecting duct (CD)
(Ackermann et al., 2010). In volume depletion, MR signaling
in principal cells increases Na+ reabsorption via the epithelial
Na+ channel (ENaC) and Cl absorption via paracellular fluxInc.
Figure 1. Phosphorylation Sites in Human MR
(A) Sites phosphorylated in MR in COS-7 cells are shown. Sites in motifs suggesting phosphorylation by proline-directed kinases (in red), glycogen synthase
kinase-3 (blue), casein kinase II (purple), calmodulin kinase II (magenta), or no known kinase (black) are indicated.
(B) MS/MS spectrum of phosphopeptide containing S843-P is shown. The phosphorylated precursor ion, 911.733+, was selected and produced the fragment ion
spectrum shown. Specific y and b fragment ions allowed assignment of phosphorylation at S843. Underline denotes oxidized methionine.
(C) Conservation of S843 among MR orthologs. S.s., Saimiri sciureus; R.n., Rattus norvegicus; M.m.,Mus musculus; G.g., Gallus gallus; A.c., Anolis carolinensis;
X.t., Xenopus tropicalis. Below is the sequence of human glucocorticoid receptor (GR); S843 is substituted to proline in all GRs.
(D) Location of S843 in the crystal structure of MR bound to aldosterone (PDB accession code 2AA2) (Bledsoe et al., 2005). Aldosterone (magenta), a helices
(green) (H1-H11), loops (gray), and S843 (orange) are indicated. (Inset) H6-H7 loop showing hydrogen bonding of S843 side-chain hydroxyl with main-chain
carbonyl and amino groups of M840 and M845, respectively. See also Figure S2.
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MR Phosphorylation Regulates Ligand Binding(Beauwens et al., 1986). Signaling in DCT increases activity of the
thiazide-sensitive Na-Cl cotransporter (NCC) (Reilly and Ellison,
2000). These activities maintain intravascular volume (see Fig-
ure S1A online). In hyperkalemia, MR-dependent reabsorption
of Na+ via ENaC provides a lumen-negative potential, driving
renal K+ secretion via the renal outer medullary K+ (ROMK) chan-
nel (Figure S1B).
Consistentwith these effects, gain-of-functionmutations inMR
lead to severe hypertension, often with hypokalemia (Geller et al.,
2000). Conversely, loss-of-function mutations result in neonatal
hypotension (Geller et al., 1998). Moreover, MR antagonists
(MRAs) are effective antihypertensive drugs (Pitt et al., 2003).
In addition to these classical pathways, other mechanisms for
electroneutral Na-Cl reabsorption in the distal nephron have
been identified (Leviel et al., 2010; Wall and Pech, 2008). Com-
bined activities of the apical H+ ATPase of a-intercalated cells
and the apical Cl/HCO3
 exchanger (encoded by Slc26a4,
Pendrin) of b-intercalated cells can couple ENaC-mediated
Na+ reabsorption and Cl reabsorption. Recently, an apical
Na+-dependent Cl/HCO3
 exchanger (NDCBE) was implicated
in electroneutral Na-Cl reabsorption via intercalated cells (Fig-
ure S1C) (Leviel et al., 2010). The roles of MR signaling in these
processes are unknown.
Aldosterone production in both volume depletion and hyper-
kalemia poses a paradox: how does the kidney maximize
Na-Cl reabsorption and minimize K+ secretion in response to
aldosterone in hypovolemia but maximize K+ secretion in hyper-
kalemia? Explicit regulation of this balance is demonstrated by
a Mendelian disease, pseudohypoaldosteronism type II (PHAII),
in which aldosterone constitutively promotes renal Na-Cl reab-Cell Msorption without K+ secretion, producing hypertension and
hyperkalemia. Mutations in kinases WNK1 and WNK4 (Wilson
et al., 2001) cause PHAII via increased renal Na-Cl reabsorption
(Wilson et al., 2003; Yang et al., 2003; Lalioti et al., 2006) and
inhibition of K+ secretion (Kahle et al., 2003). Similarly, mutations
in ubiquitin ligase components CUL3 and KLHL3 (Boyden et al.,
2012) cause PHAII by loss of degradation of WNKs (Shibata
et al., 2013; Wakabayashi et al., 2013). WNK4 function is regu-
lated by AII (San-Cristobal et al., 2009), suggesting AII signaling
may play a role in the discrimination of these two states (Kahle
et al., 2008). AII receptors are found on DCT, principal, and inter-
calated cells (Rothenberger et al., 2007).
We report identification of a phosphorylation site in the LBD of
MR that regulates ligand binding and receptor activation, and we
implicate this phosphorylation in producing distinct responses to
aldosterone in volume depletion and hyperkalemia.
RESULTS
Identification of MR Phosphorylation Sites
FLAG-epitope-tagged human MR (Shibata et al., 2008) was
expressed in COS-7 cells and purified by immunoprecipitation
(IP) and SDS-PAGE. Samples were digested with trypsin, and
phosphopeptides were purified using a TiO2 matrix. Resulting
peptides were identified by LC-MS/MS; phosphopeptides and
specific sites of phosphorylation were assigned by the precise
match of predicted and observed m/z ratios of precursor ions
and their product fragment ions. In three independent mapping
experiments, we reproducibly observed 16 phosphorylation
sites in MR (Figures 1A and S2). Fourteen sites were in theetabolism 18, 660–671, November 5, 2013 ª2013 Elsevier Inc. 661
Figure 2. S843 Phosphorylation Inhibits MR Transactivation by Abrogating Ligand Binding
(A and B) Induction of luciferase under control of the MMTV promoter in COS-7 cells by wild-type (WT) MR and MR with the phosphomimetic S843E mutation in
the presence or absence of 1 nM aldosterone (A) or 100 nM cortisol (B). Luciferase activity is expressed as percent of WT MR activity in the presence of ligand.
Aldo, aldosterone; Cort, cortisol. Mean ± SEM is shown; n = 6 independent assays in each group; **p < 0.01.
(C) Localization of WT or mutant MR in nuclear and cytoplasmic fractions in the presence of 1 nM aldosterone. a-MR detects no signal without expression of MR.
Unlike MRWT, MRS843E is almost exclusively cytoplasmic.
(D) Affinity of [3H]aldosterone for MR. MRWT andMRS843E were expressed in COS-7 cells, and the binding affinity for [3H]aldosterone and Scatchard analysis was
performed. Each data point was analyzed in duplicate, and the mean value is shown. MRS843E shows drastically reduced ligand binding. See also Figure S3.
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MR Phosphorylation Regulates Ligand Bindingamino-terminal domain, one each in the hinge region and LBD,
and none in the DNA-binding domain. Sites identified included
S129 and S250, previously reported to be phosphorylated
in vitro by cyclin-dependent kinase 5 (Kino et al., 2010), and
S361, phosphorylated by extracellular signal-related kinase
(ERK) (Faresse et al., 2012); the remainder have not been
reported. Nine amino-terminal and the hinge region phosphor-
ylation sites harbored the minimal substrate motif (S-P) for
phosphorylation by proline-directed kinases such as p38. Candi-
date kinases for other sites in the amino terminus included
glycogen synthase kinase-3, casein kinase II, and calmodulin
kinase II. The sole phosphorylation site in the ligand-binding
domain, at serine 843 (S843) (Figures 1A and 1B), matched no
known kinase motif.
Phosphorylation at S843 in the LBD was of particular interest.
Serine at this position is conserved among orthologs from frogs
to humans (Figure 1C). This site is implicated in the specificity
of ligand binding. MR and glucocorticoid receptor (GR) evolved
from a common MR-like ancestor. MR binds both mineralo-
corticoids (e.g., aldosterone) and glucocorticoids (e.g., cortisol),
while GR selectively binds glucocorticoids. GR specificity
derives from two substitutions in the LBD, one changing S843
in MR to proline (Ortlund et al., 2007). This suggested that phos-
phorylation of S843 might alter ligand binding and receptor
activation. In the crystal structure of MR, S843 lies in the loop
connecting H6 and H7 helixes of the LBD. In the ligand-bound
state, the hydroxyl group of S843 forms hydrogen bonds with
the carbonyl oxygen of M840 in helix H6 and the amino group
of M845 (Figure 1D) (Bledsoe et al., 2005). Because these inter-
actions stabilize the relationship between H6 and H7, phosphor-
ylation of S843 might affect ligand binding and activation.
Phosphorylation at S843 Inactivates MR by Preventing
Ligand Binding
We examined the effect of phosphorylation of S843 on the ability
of MR to activate transcription of a luciferase reporter gene
under control of the MR-responsive mouse mammary tumor
virus (MMTV) promoter. Plasmids encoding wild-type (WT) MR
(MRWT) or MR with either a phosphomimetic glutamate substitu-662 Cell Metabolism 18, 660–671, November 5, 2013 ª2013 Elseviertion at position 843 (MRS843E) or a nonphosphorylatable alanine
substitution MRS843A were expressed in COS-7 cells in the pres-
ence or absence of physiologic concentrations of aldosterone
(1 nM) or cortisol (100 nM). Activation of MRWT with either aldo-
sterone or cortisol produced a >30-fold increase in luciferase
activity (Figures 2A and 2B). MRS843A showed similar activation
(Figure S3A). In contrast, while expressed at levels indistinguish-
able from MRWT, MRS843E was not activated by either hormone
(Figures 2A and 2B). No similar effects were observed at other
MR phosphorylation sites tested with phosphomimetic or
alanine substitutions (Figure S3A).
Apo-MR is normally cytoplasmic; aldosterone binding allows
translocation to the nucleus (Pratt, 1997). We analyzed the sub-
cellular distribution of WT and mutant MR by western blotting
using a-MR antibodies in nuclear and cytoplasmic fractions.
Both MRWT and MRS843A were abundant in the nucleus in the
presence of 1 nM aldosterone (Figure 2C). In contrast, MRS843E
was virtually exclusively cytoplasmic. This conclusion was
reinforced by IF microscopy of COS-7 cells expressing MRWT
or MRS843E tagged with GFP (Figure S3B).
We evaluated receptor affinity for 3H-labeled aldosterone for
WT and mutant MR. The dissociation constant for aldosterone
binding toMRWTwas 0.6 nM, consistent with prior studies (Arriza
et al., 1987; Geller et al., 2000). In contrast, the dissociation
constant for MRS843E was 86 nM, a >130-fold increase (Figures
2D and S3C). This loss of ligand binding explains the loss of
transcriptional transactivation and persistence of MR in the
cytoplasm.
MRS843-P Localizes to the Cytoplasm of Renal
Intercalated Cells
We produced antibodies that specifically recognize MR phos-
phorylated at S843 (MRS843-P) using an immunizing peptide
that is identical in human and mouse. These antibodies
selectively recognized synthetic MR peptide phosphorylated at
S843, but not unphosphorylated peptide (Figure 3A). Western
blotting of lysates from COS-7 cells expressing MRWT identified
a protein of the expected size (Figure 3B); this signal was abol-
ished by alkaline phosphatase (Figure 3C) and absent in lysatesInc.
Figure 3. MRS843-P Is Exclusively Cytoplasmic in Renal Intercalated Cells
(A) Antibodies specific for MRS843-P (a-MRS843-P) were incubated with phosphorylated and nonphosphorylated MR peptides spotted on a nitrocellulose
membrane, followed by staining with peroxidase-conjugated donkey anti-rabbit antibody. The results demonstrate specificity for the phosphopeptide.
(B) Western blot of COS-7 cell lysates expressing humanMR using antibodies to total MR orMRS843-P. Samples were loaded in duplicate. a-MRS843-P specifically
recognizes a protein the size of MR.
(C) Phosphatase treatment eliminates a-MRS843-P signal. FLAG-tagged human MR was purified, incubated with or without calf intestinal alkaline phosphatase
(CIP), and analyzed by western blotting (see also Figure S4B).
(D) Expression of MRS843-P in kidney. Total kidney lysates were prepared from mice fed normal chow and subjected to western blotting with a-MRS843-P.
The results from two mice are shown.
(E) Specificity of a-MRS843-P in kidney lysates. Western blots of total kidney lysates fromWTmice were stained with a-MRS843-P without or with CIP treatment and
then without peptide competition, with competition using the nonphosphorylated version of the immunizing MR peptide, then competition with the immunizing
MR phosphopeptide. Phosphatase treatment or competition with immunizing phosphopeptide eliminates the antibody signal.
(F) Mouse kidney lysates were fractionated into nuclear and cytoplasmic fractions and stained with a-MR and a-MRS843-P antibodies. Total MR is predominantly
nuclear; MRS843-P is confined to the cytoplasm.
(G) COS-7 cells expressingMR-GFPwere stained with a-MRS843-P antibody (red) and DAPI (blue) 1 hr after the addition of 1 nM aldosterone. Arrows indicate cells
expressingMR-GFP, whichwere detected by fluorescencemicroscopy. MR-GFPwasmainly nuclear, with less signal in the cytoplasm. In contrast, MRS843-P was
virtually exclusively cytoplasmic. No MRS843-P signal was detected in cells that did not express MR-GFP (asterisks). Scale bar represents 10 mm.
(H) WT mouse kidney sections were stained for a-MRS843-P (green) or AQP2 (a marker of principal cells in the CD, red). MRS843-P is cytoplasmic and only seen in
AQP2-negative cells (intercalated cells).
(I) Kidney sections were costained for MRS843-P (green) and AE1 (red), which is expressed on the basolateral membrane of a-intercalated cells. MRS843-P is found
in AE1-positive cells (arrows) and also in some AE1-negative cells (asterisks, which are inferred to be b-intercalated cells; confirmed in Figure S4E).
(J) Kidney sections stained for a-MR (red) and a-MRS843-P (green). Total MR is predominantly nuclear with half the cells (inferred to be intercalated cells) also
showing cytoplasmic staining for MRS843-P. Scale bars represent 50 mm in (H)–(J). See also Figure S4.
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MR Phosphorylation Regulates Ligand Bindingexpressing no MR or MRS843A (Figure S4A). These results estab-
lish the specificity of this antibody for MRS843-P.
The subcellular distribution of MR with and without S843-P
in COS-7 cells was evaluated by expressing MR-GFP (Shibata
et al., 2008). In the presence of 1 nM aldosterone, total MR
(identified by GFP fluorescence) was predominantly nuclear,
with modest cytoplasmic staining. In contrast, MRS843-P was
confined to the cytoplasm (Figure 3G).
We surveyed tissues for MRS843-P using this a-MRS843-P anti-
body. By western blotting, we identified a protein of the appro-
priate size in kidney, but not in other tissues known to express
MR (Figures 3D and S4C). This kidney signal is abolished by
phosphatase treatment and by competition with the immunizing
MR phosphopeptide, but not with unphosphorylated peptide
(Figure 3E). Kidney homogenates fractionated into nuclear and
cytoplasmic fractions showed that total MR was predominantly
nuclear, while MRS843-P was exclusively cytoplasmic (Figure 3F).
Immunofluorescence (IF) microscopy was used to determine
the nephron segments and cell types that express MRS843-P.
Mouse kidneys were stained with a-MRS843-P and either a-aqua-
porin 2 (AQP2), a marker of principal cells in the CNT and CD, or
a-calbindin, an abundant protein in DCT. The results showed
that MRS843-P was confined to distal nephron segments that
also stain for AQP2 (i.e., CNT and CD, Figure S4D). Surprisingly,
in these distal nephron segments, MRS843-P was found not in
principal cells but instead exclusively in adjacent AQP2-negative
epithelial cells (Figure 3H), which are presumptively a-interca-
lated and/or b-intercalated cells. This conclusion was confirmed
by costaining for the Cl/HCO3
 exchangers AE1, found in
a-intercalated cells (Alper et al., 1989) (Figure 3I), and pendrin,
found in the b-intercalated cells (Frische et al., 2003) (Figure S4E).
MRS843-P was found in both intercalated cell types. Moreover,
MRS843-P was confined to the cytoplasm in both (Figures 3H–
3J). This localization was also found in human kidney (Figures
S4F and S4G).
Volume Depletion and High Dietary Potassium Have
Opposite Effects on MRS843-P
We reasoned that there must be physiologic states that modu-
late S843 phosphorylation, converting the inactive phosphory-
lated form to a competent dephosphorylated form receptive
to ligand. Because aldosterone secretion occurs with reduced
intravascular volume or hyperkalemia, we examined levels of
MRS843-P when these parameters were changed. Intravascular
volume was modulated by feeding mice high- or low-NaCl diets;
we also compared littermates that wereWT or homozygous defi-
cient for the Na-Cl cotransporter NCC, encoded by Slc12a3,
which results in volume depletion and activation of the RAS
(Loffing et al., 2004). Low-NaCl diet resulted in a 50% reduction
in MRS843-P (p = 0.001, Figure 4A). Similarly, a 62% reduction
was seen in Slc12a3/ mice (p = 0.007, Figure 4B). In both
cases, levels of total MR were unaltered. IF microscopy demon-
strated that MRS843-P is markedly reduced in both a- and b-inter-
calated cells in Slc12a3/ (Figure 4C). Conversely, high-K+ diet
produced a marked increase in MRS843-P (2.2-fold increase, p =
0.0008) (Figure 4D). Moreover, intercalated cell MRwas predom-
inantly cytoplasmic with high K+ (Figure S5A, upper two panels)
but was predominantly nuclear in Slc12a3/ (Figure S5A, lower
two panels). This is in contrast to the adjacent principal cells, in664 Cell Metabolism 18, 660–671, November 5, 2013 ª2013 Elsevierwhich MR is nuclear in both conditions (Figure S5A). These
results suggest that intercalated cell MR is inhibited when
increased K+ secretion is required but is competent for activa-
tion in volume depletion.
Given the classical role of intercalated cells in acid/base
physiology, we also tested whether MRS843-P is modulated
with changes in acid/base status. Acid loading was achieved
by addition of NH4Cl to the drinking water. This acid load induced
the expected reduction in urinary pH, but western blot analysis
revealed that MRS843-P levels were not significantly altered
(Figures S5B and S5C).
AII Signaling Produces Dephosphorylation of MRS843-P
The modulation of MRS843-P in opposite directions with volume
depletion and potassium loading suggested that MRS843-P might
help orchestrate the different renal responses required in these
two states. While both feature elevated aldosterone levels,
only volume depletion produces increased AII. This observation,
and the presence of AII receptors on intercalated cells (Rothen-
berger et al., 2007), suggested that AII signaling might contribute
to dephosphorylation of MRS843-P. We tested whether mice defi-
cient for the AII type 1a receptor (Agtr1a/) modulatedMRS843-P
levels when changed from a high- to low-salt diet. Agtr1a/
mice showed no reduction in MRS843-P on low salt (Figure 4E),
implicating AII signaling in dephosphorylation of MRS843-P in
volume depletion.
To directly test whether AII reduces levels of MRS843-P, WT
mice on high-NaCl diet received continuous infusion of AII
(1 mg/kg/min, subcutaneously). This produced a 75% reduction
in MRS843-P with no change in total MR (Figures 4F and 4G).
This effect was blocked by coadministration of losartan, an
AII receptor blocker (ARB) (Figure 4F). IF microscopy confirmed
that MRS843-P was markedly reduced in both a- and b-interca-
lated cells (Figure 4H). These results demonstrate that AII
signaling in the absence of volume depletion is sufficient to
promote dephosphorylation of intercalated cell MRS843-P.
Reduced MRS843-P Increases Expression of Electrolyte
Flux Mediators in Intercalated Cells
Dephosphorylation of MRS843-P should produce receptor
competence, allowing signaling in response to aldosterone.
Likely MR targets in intercalated cells are mediators of electro-
lyte flux expressed in these cells. These include the multisubunit
apical H+ ATPase and the basolateral Cl/HCO3
 exchanger
AE1, both present in a-intercalated cells, and pendrin, an apical
Cl/HCO3
 exchanger in b-intercalated cells. We examined the
expression of each of these by western blotting (the apical H+
ATPase was assayed by levels of the B1 subunit, which is spe-
cific for the apical H+ ATPase [Finberg et al., 2003]) (Figures 5
and S6). The results showed that levels of both the B1 subunit
of the H+ ATPase and pendrin were significantly increased with
AII infusion and decreased with high dietary K+ (Figure 5A). Simi-
larly, both were elevated in Slc12a3/ mice (Figure 5B), with
increased apical membrane staining of the B1 subunit and
pendrin (Figure S6D). These increases are dependent on AII
signaling, as they are reversed by the selective AGTR1 inhibitor
losartan (Figure 5C). Losartan also blocked the reduction in
MRS843-P levels in Slc12a3/ (Figure S6F), consistent with AII
regulating MRS843-P dephosphorylation. MRA spironolactone,Inc.
Figure 4. Changes in MRS843-P with Volume Depletion, K+ Loading, and AII Signaling
(A) MRS843-P and total MR levels in kidneys of WT mice fed a high-salt (HS) or low-salt (LS) diet determined by western blot in biological replicates. Bar graphs
show results of densitometric quantitation (n = 4 in each group).
(B) Levels of MRS843-P in the kidneys of mice lacking NCC (Slc12a3/) and WT littermates (n = 4). MRS843-P is reduced in Slc12a3/.
(C) Immunofluorescence microscopy of MRS843-P (green) and AE1 (red) in kidneys of WT and Slc12a3/ mice. MRS843-P is markedly reduced in Slc12a3/.
(D) MRS843-P levels are increased in kidneys of WT mice eating a high-K+ diet compared to normal diet (n = 4).
(E) MRS843-P in kidneys of mice lacking type 1A AII receptor (Agtr1a/) fed a high- or low-NaCl diet (n = 4). Low-salt diet fails to reduce levels of MRS843-P in
Agtr1a/.
(F) AII infusion in WT mice fed high-NaCl diet reduces MRS843-P levels; effect is prevented by an AII receptor blocker (ARB).
(G) Quantitation of MRS843-P in the kidneys described in (F) (n = 3 or 4).
(H) Microscopy showing presence ofMRS843-P (green) and AQP2 (red) in kidneys of mice fed high-NaCl diet or high-NaCl diet with AII infusion. AII infusion reduces
levels of MRS843-P.
All error bars represent mean ± SEM; **p < 0.01. Scale bar represents 50 mm in (C) and (H). See also Figure S5.
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ure S6F). Critically, if these effects of AII on intercalated cells
require MR signaling, they should be prevented by MRA. This
is indeed the case (Figure 5D). These findings establish that AII
plus aldosterone signaling in intercalated cells together increase
levels of the apical H+ ATPase and pendrin, with increased die-
tary K+ having the opposite effect, despite elevated aldosterone
levels. These changes are likely adaptive in the physiologic
responses to volume depletion and hyperkalemia (see below),Cell Mas the combined activities of these electrolyte flux mediators
are implicated in renal Na-Cl reabsorption (Pech et al., 2008;
Soleimani et al., 2012).
In contrast, we found no significant effects of AII on AE1
expression (Figures S6B and S6C). Additionally, NDCBE
appears to be regulated through an AII-dependent, MR-inde-
pendent pathway, because AII increased NDCBE, but MRAs
did not reverse these effects; moreover, hyperkalemia did not
alter NDCBE levels (Figures S6B, S6C, and S6E).etabolism 18, 660–671, November 5, 2013 ª2013 Elsevier Inc. 665
Figure 5. Modulation of MRS843-P Alters Pendrin and B1 H+ ATPase in Intercalated Cells
(A) Expression of pendrin and B1 H+ ATPase in the membrane fraction of kidneys from indicated mice was analyzed by western blotting. Blots show biological
replicates. Bar graphs show densitometric quantitation comparing levels of pendrin and B1 H+ ATPase in indicated animals (n = 4 or 5 in each group).
(B) Membrane expression of pendrin and B1 H+ ATPase in the kidneys obtained from WT and Slc12a3/ (n = 4).
(C) Effects of ARB on pendrin and B1 H+ ATPase membrane expression in the kidneys of Slc12a3/ (n = 4).
(D) Effects of MR antagonist (MRA) spironolactone on pendrin and B1 H+ ATPase membrane expression in the kidneys of Slc12a3/ mice (n = 4).
Data are expressed as mean ± SEM; *p < 0.05, **p < 0.01. See also Figure S6.
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The opposing effects of volume depletion and dietary K+ on
levels of MRS843-P, and the effect of MR signaling in intercalated
cells to modulate electroneutral Na-Cl reabsorption pathways
(see below), suggest a potential role for the kinase WNK4
because of its known role in regulating the balance between
Na-Cl reabsorption and K+ secretion (Kahle et al., 2008; Wilson
et al., 2001). Staining of mouse kidney with antibodies to
WNK4 and markers of principal and intercalated cells demon-
strated clear expression of WNK4 in intercalated cells (Figures
6A and S7A). We consequently investigated the effect of gain-
and loss-of-function mutations in WNK4 on levels of MRS843-P.
The TgWNK4Q562E mouse (Lalioti et al., 2006) carries one extra
copy of the Wnk4 genomic locus harboring the gain-of-function
Q562E mutation found in humans with hypertension and hyper-
kalemia (PHAII). Compared to WT littermates, these mice have
a 62% lower levels of MRS843-P (p = 0.017; Figure 6B). This is
likely a primary effect of this mutation, since these mice have
increased Na-Cl reabsorption, hypertension, and hyperkalemia
(Lalioti et al., 2006), conditions that would otherwise be expected
to increase MRS843-P levels. Conversely, the Wnk4 knockout
mouse (Castan˜eda-Bueno et al., 2012) shows significantly
increased levels of MRS843-P (Figure S7B). These findings are
consistent with WNK4 lying downstream of AII signaling in inter-
calated cells, as has been shown in DCT (San-Cristobal et al.,
2009), and are consistent with WNK4Q562E phenocopying AII
signaling.
We evaluated the consequences of MRS843-P dephosphoryla-
tion in TgWNK4Q562E mice. At baseline, pendrin was slightly
decreased and B1 H+ ATPase was not different from WT litter-666 Cell Metabolism 18, 660–671, November 5, 2013 ª2013 Elseviermates (Figure S7C), likely attributable in part to the acidosis
seen in this model (Lalioti et al., 2006), as acidosis directly down-
regulates pendrin (Frische et al., 2003). We reasoned that the
effect of MRS843-P dephosphorylation may not be apparent
in these mice, because, like their human counterparts, they do
not have elevated serum aldosterone owing to suppressed
plasma renin activity (Figure S7D). However, since MR is
dephosphorylated, we expected that aldosterone should be
capable of activating intercalated cell MR in this model. We
thus infused aldosterone (50 mg/kg/day, s.c.) (Leopold et al.,
2007) to TgWNK4Q562E and WT littermates. Aldosterone infusion
did not alter the levels of MRS843-P (Figure S7E) but caused a
marked increase in pendrin (2.7-fold increase, p < 0.0001) and
B1 H+ ATPase (2.1-fold increase, p < 0.0001) in TgWNK4Q562E
mice (Figures 6C and 6D). By contrast, aldosterone failed to
upregulate pendrin and only marginally elevated B1 H+ ATPase
inWT littermates (Figures 6C and 6D). These results demonstrate
that the MR-mediated increase in pendrin and B1 H+ ATPase
depends on both MRS843-P dephosphorylation and aldosterone.
NDCBE was upregulated in TgWNK4Q562E mice (Figure S7F),
consistent with WNK4Q562E phenocopying AII signaling (San-
Cristobal et al., 2009). The levels of NDCBE were not altered
by aldosterone infusion in WT or TgWNK4Q562E mice (Fig-
ure S7G), confirming that NDCBE is regulated independently of
MR signaling.
To identify the phosphatase responsible for dephosphoryla-
tion of MRS843-P, we incubated purified FLAG-MR with protein
phosphatases PP1, PP2A, and PP2B and assayed MRS843-P
by western blotting. Incubation with PP1 markedly reduced
MRS843-P, while other phosphatases did not (Figure S4B),Inc.
Figure 6. Role of WNK4 in Regulation of MRS843-P
(A) Perfusion-fixed WT kidney sections were stained with a-WNK4 (green) or AQP2 (red). WNK4 is present in both AQP2-positive principal cells and in
AQP2-negative intercalated cells (arrows; see also Figure S7A). Scale bar represents 50 mm.
(B) MRS843-P levels in kidneys of TgWNK4Q562E mice carrying PHAII mutant WNK4 (Q562E) and WT mice. Blots show biological replicates. Bar graphs show
results of quantitation (n = 4). Data are expressed as mean ± SEM; *p < 0.05.
(C and D) Effects of aldosterone infusion on the levels of pendrin and B1 H+ ATPase in membrane fractions of kidneys from WT and TgWNK4Q562E mice. Bar
graphs in (D) show the results quantitation in aldosterone-treated animals compared to controls (n = 6). Data are expressed as mean ± SEM.
(E) Parallel changes in levels of MRS843-P, pendrin, and B1 H+ ATPase in response to physiologic and genetic manipulations. Levels of MRS843-P are inversely
related to levels of B1 H+ ATPase and pendrin; the increase in pendrin and B1 levels with dephosphorylated receptor is dependent upon aldosterone. Red
indicates increased and green indicates decreased levels.
(F) Correlation of MRS843-P and pendrin or B1 H+ ATPase levels. Each data point compares the response of MRS843-P and either pendrin (left) or B1 H+ ATPase
(right) in each physiologic or genetic manipulation described in (E) (comparisons of Slc12a3/ + MRA to Slc12a3/, and of Tg-WNK4Q562E to WT, in which
aldosterone levels are not increased, are not included). For MRS843-P levels in Tg-WNK4Q562E + aldosterone group, levels in WT mice are used as reference.
See also Figure S7.
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and PP1 (Lin et al., 2012).
DISCUSSION
We identified a phosphorylation site in the LBD of MR that ren-
ders the receptor incapable of ligand binding and activation;
dephosphorylation results in aldosterone-dependent increases
in proteins mediating intercalated cell electrolyte flux.
Across all experiments, the quantitative changes in MRS843-P
are highly correlated with changes in pendrin and B1 H+
ATPase (Figures 6E and 6F). Demonstration that increases in
pendrin and B1 H+ ATPase require MR signaling provides strong
evidence of a causal relationship.Cell MMRS843-P was found exclusively in renal intercalated cells, and
its levels are modulated in opposite directions by the physiologic
stimuli for aldosterone secretion, volume depletion, and hyper-
kalemia. Dephosphorylation in volume depletion is dependent
on AII signaling and a downstream kinase, WNK4. Dephosphor-
ylation restoresMR competence and aldosterone-dependent in-
creases of intercalated cell proteins that are adaptive to volume
depletion (Figure 7). Increased apical H+ ATPase and Cl/HCO3

exchange activity increases net Cl reabsorption, which in
conjunction with aldosterone-induced Na+ reabsorption by
ENaC increases electroneutral Na-Cl reabsorption (Figure 7D)
(Wall and Pech, 2008). In contrast, hyperkalemia increases phos-
phorylation of MRS843, reducing levels of these proteins; in this
setting, the lumen-negative potential from ENaC activity drivesetabolism 18, 660–671, November 5, 2013 ª2013 Elsevier Inc. 667
Figure 7. Physiologic Role of MRS843-P in Response to Hyperkalemia and Volume Depletion
(A) Mechanism for MR-dependent regulation of pendrin and B1 H+ ATPase in intercalated cells. High K+ increases MRS843-P, which prevents activation of MR by
ligand. Dephosphorylation of MRS843-P in response to AII signaling restores receptor competence and upregulation of pendrin and B1 H+ ATPase in response to
aldosterone.
(B) The major apical electrolyte flux mediators seen in the three major cells types of the CNT and CD of the distal nephron are shown. MR is present in all three;
however, MRS843-P (denoted ‘‘P’’) is only seen in intercalated cells.
(C) In hyperkalemia, aldosterone binds and activatesMR in principal cells, but not in intercalated cells. This increases electrogenic Na+ reabsorption via ENaC and
provides the lumen-negative potential required for K+ secretion.
(D) In volume depletion, in addition toMR signaling in principal cells, AII signaling reducesMRS843-P, which results inMR signaling in intercalated cells. This results
in Cl reabsorption via the combined activities of the apical H+ ATPase and the apical Cl/HCO3
 exchanger pendrin. Increased Cl reabsorption neutralizes the
lumen-negative potential, preventing increased K+ efflux. AGTR1, AII type 1 receptor. See also Figure S1.
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promoting alternative responses to hypovolemia and hyperka-
lemia. These findings indicate the key role of AII signaling in
switching the response to aldosterone from K+ secretion to
Na-Cl reabsorption and reveal how MR signaling can produce
different responses to distinct physiologic conditions.
These conclusions are supported by prior work implicating
b-intercalated cells in Cl reabsorption in the CD (Wall andWein-
stein, 2013). Moreover, while Slc12a3/mice have modest salt
wasting, adding Pendrin (Slc26a4) deficiency results in severe
salt wasting, implicating pendrin in the normal adaptation to vol-
ume depletion (Soleimani et al., 2012). Our finding that MRS843-P
is dephosphorylated in Slc12a3/ mice, resulting in upregula-
tion of pendrin and H+ ATPase, provides a mechanism for this
compensation. We also infer that the metabolic alkalosis found
in the double knockout mouse model can be explained by upre-
gulation of apical H+ ATPase without upregulation of pendrin
(Figure 7A).
AII also increases NDCBE levels independent of MR. This sug-
gests the potential to respond to combined volume depletion
and hyperkalemia by induction of this intercalated cell Na-Cl668 Cell Metabolism 18, 660–671, November 5, 2013 ª2013 Elsevierreabsorption pathway while maintaining K+ secretion due to
the lumen-negative electrical gradient established by ENaC.
The recognition of MR-dependent and independent pathways
for salt reabsorption in the distal nephron raises the possibility
for improved antihypertensive agents.
Biochemical details of the pathways that mediate and regulate
MRS843-P remain to be established. While dephosphorylation of
S843 lies downstreamof AII andWNK4 signaling, likelymediated
by PP1, the intermediate steps are unknown. Specificity of phos-
phorylation at S843 could be achieved by selective expression of
the responsible kinase in intercalated cells. It will be of interest
to identify the kinase that directly phosphorylates S843 and
the pathway linking hyperkalemia to increased S843 phosphory-
lation. Although knockdown of WNK1 with siRNA reduced
MRS843-P levels by 32%, purified WNK1 did not phosphorylate
MRS843-P in vitro, suggesting that WNK1 does not directly
phosphorylate MRS843 (Figures S7H and S7I). We predict that
prevention of phosphorylation at 843 would produce hyperten-
sion and hyperkalemia.
Lastly, 11bHSD2, which metabolizes cortisol to the inactive
metabolite cortisone (Funder et al., 1988), is thought to be absentInc.
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DinhCat et al., 2010), posing the question of howMR is regulated
in these cells. The finding of regulated ligand binding motivates
further efforts to determine whether the same or related mecha-
nisms may regulate MR activity in other tissues, and also
whether posttranslational modification of other LBDs might
play analogous roles to regulate ligand binding and activation.
EXPERIMENTAL PROCEDURES
Detailed methods are found in the Supplemental Experimental Procedures.
Identification of Phosphorylation Sites in MR
IP and LC-MS/MS were performed as described previously (Rinehart et al.,
2009). Human MR with an N-terminal FLAG epitope (Shibata et al., 2008)
was expressed in COS-7 cells and purified from cell lysates by FLAG-IP fol-
lowed by SDS-PAGE. The resulting protein was digested with trypsin, and
phosphopeptides were purified using TiO2 affinity. Peptides were analyzed
bymass spectrometry. The location of S843 inMR determined from the crystal
structure of human MR bound to aldosterone (Protein Data Bank accession
code 2AA2) (Bledsoe et al., 2005).
Analysis of MR Function
Transcriptional activity and ligand binding of WT and mutant MR were evalu-
ated by luciferase reporter assay and receptor binding assay as described
previously (Geller et al., 2000).
Western Blotting
Indicated cells and tissues were lysed and total protein, membrane, and
nuclear and cytoplasmic fractions were prepared, subjected to western blot-
ting, and probed with indicated antibodies.
To produce antibodies specific for MR phosphorylated at S843, the human
MR peptide CKK-DLVFNEEKMHQS*AMYEL (*phospho-Ser), conjugated to
CKK at the amino terminus, was coupled to keyhole limpet hemocyanin, and
rabbits were immunized with the phosphopeptide (Covance Research Prod-
ucts). Pooled serum was depleted of nonspecific antibodies with the cognate
nonphosphopeptide, and specific antibody was purified with the immunizing
phosphopeptide. The antibody was used at a dilution of 1:100 for immuno-
staining and 1:3,000 for western blotting. In some experiments, samples
were incubated with calf intestinal phosphatase at 37C before western blot-
ting. Other antibodies included antibodies to pendrin (1:10,000 for western
blot and 1:400 for immunostaining; a gift from P. Aronson, Yale University);
B1 H+ ATPase (1:1,000 for Western blot and 1:100 for immunostaining, a gift
of D. Brown, Massachusetts General Hospital); AE1 (1:100 for immunostain-
ing, a gift of D. Biemesderfer, Yale University); MR (1:400 for western blotting
and 1:50 for immunostaining, a gift of Dr. C.E. Gomez-Sanchez, University of
Mississippi Health Center); AQP2 (1:250, Santa Cruz); WNK4 (1:100, prepared
in our laboratory) (Wilson et al., 2001); NDCBE (1:1,000, Proteintech); FLAG
(1:2,000), histone 1.4 (1:1,000), and a-tubulin (1:5,000) (all from Sigma); and
11bHSD2 (1:500, Millipore).
Immunofluorescence Microscopy
Cryosections from perfusion-fixed mouse kidneys or paraffin-embedded
human kidney sections (use of normal human kidney from tissue removed at
surgery for renal cancers was approved by Yale IRB) were incubated with indi-
cated primary antibodies and secondary antibodies as described previously
(Shibata et al., 2008).
Animal Studies
Mice were bred and maintained with approval by the Yale Institutional Animal
Care andUse Committee. Mice studied includedWTC57BL/6mice,Agtr1a/
mice (Ito et al., 1995) in the C57BL/6 background, Slc12a3/ mice (Loffing
et al., 2004) maintained on a mixed C57/BL6-129/SvJ background and WT
littermates, Wnk4/ mice in a C57/BL6-129/SvJ background (Castan˜eda-
Bueno et al., 2012) and WT littermates, and mice transgenic for genomic seg-
ments harboring PHAII mutant Wnk4 (Q562E; TgWNK4Q562E) (Lalioti et al.,
2006) in the C57BL/6 background. Dietary manipulations included high (8%)Cell Mor low (0.03%) NaCl diet maintained for 12 days, and a high (5%) or normal
(0.9%) K+ diet for 7 days. For acid loading, drinking water contained 0.28 M
NH4Cl/1% sucrose for 7 days. Pharmacologic manipulation included sub-
cutaneous infusion of 1 mg/kg/min AII or vehicle via osmotic minipump for
7 days (Gonzalez-Villalobos et al., 2008); the ARB losartan was administered
orally at a dose of 30 mg/kg/day. The MRA spironolactone was given orally
(0.2 g/kg chow). Aldosterone was administered subcutaneously at a dose of
50 mg/kg/day for 7 days (Leopold et al., 2007).
RNA Interference Studies and Kinase Assays
Previously characterized siRNA for WNK1 (Rinehart et al., 2009) or control
siRNA was introduced into HEK cells via transient transfection. For in vitro
kinase assays, HA-tagged full-length rat WNK1 purified from COS-7 cells
was incubated with purified FLAG-tagged MR in kinase buffer with ATP. MR
phosphorylation was analyzed by western blotting and showed no increase
in S843 phosphorylation.
Statistical Analysis
The data are summarized as means ± SEM. Unpaired t tests were used for
comparisons between two groups. For multiple comparisons, statistical anal-
ysis was performed by ANOVA followed by Tukey post hoc tests. Correlation
of changes in MRS843-P and intercalated cell protein levels were tested by
Pearson’s correlation. p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article at http://dx.doi.org/10.
1016/j.cmet.2013.10.005.
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